Biotech

All Articles

Kailera launches with $400M set A, 4 Chinese excessive weight medicines

.Kailera Therapeutics has actually released into the significantly crowded excessive weight room alo...

Metsera join Amneal to latch down GLP-1 source

.Along with very early period 1 records now out in the wild, metabolic disease attire Metsera is act...

Rivus articles data to back up muscle-sparing excessive weight drug insurance claims

.Rivus Pharmaceuticals has revealed the records behind its period 2 being overweight win in heart fa...

BMS pays for $110M to create T-cell therapy deal, helping Main acquire time to advance prioritized pipe

.Bristol Myers Squibb is spending Main Medicine $110 million in advance to cultivate reagents for ex...

Generate increases another $1B-plus Significant Pharma relationship

.Novartis has printer inked a package likely worth greater than $1 billion along with Flagship-found...

Metsera GLP-1 information slice uncovers 7.5% weight-loss at 36 times

.Lately debuted Metsera is actually unfolding some stage 1 information for its GLP-1 receptor agonis...

Flagship wishes biotechs group to Mirai to improve hereditary medications

.Amidst the genetic medications branches race, Front runner Pioneering is introducing a brand-new bu...

BioAge eyes $180M coming from IPO, personal placement for obesity trials

.BioAge Labs is checking out around $180 million in first proceeds from an IPO and a private positio...

Merck's LAG-3 combo fails colon cancer stage 3 research study

.A try through Merck &amp Co. to open the microsatellite dependable (MSS) metastatic intestines canc...

Spanish VC closes $200M lifestyle sciences fund

.Spain-based Asabys Partners has closed a fund of 180 million euros ($ 200 million), money that will...